But in fact, if it weren’t for middlemen like wholesalers and pharmacy benefit managers, drug prices would be even higher. When Donald Trump was running for President in 2016, he promised to ...

President Trump is attempting to reshape America’s biotech industry with two primary objectives. He wants more medicines to ...

The drug middlemen known as pharmacy-benefit managers took another body blow from regulators on Tuesday, as they were criticized for charging way more for some “critical” prescription drugs ...

Signing into law the other criminal justice bill, named the Law and Order Act, Stein praised the effort by lawmakers to ...

Drug middlemen paid their own mail-order pharmacies as much as 200 times more than rival pharmacies for common cancer medicines, generating at least $1 billion in excess revenue and potentially ...

Americans pay more for prescription drugs than any country in the world, and the pharmaceutical industry earns billions in profits each year. Critics blame pharmacy benefit managers, or PBMs, for ...

If Democrats focused more on why drugs’ list prices have increased so much instead of capping out-of-pocket costs in Medicare, “we could have not only solved the problem for insulin but for ...

The middlemen companies negotiate rebates and discounts for insurance plans from drug manufacturers, determining the prices insurance plans pay and pharmacies receive. “People hate PBMs.

Drug middlemen, known as pharmacy-benefit managers, have accomplished something rare in Washington: Their business practices have led to a bipartisan consensus of sorts around the need for more ...

FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000% Provided by Dow Jones Jan 14, 2025, 7:46:00 PM. By Tomi Kilgore .